Sooner or later, they’re going to get one right

When I was growing up, Dad always had workshop.  One of the mantra’s I heard him repeat (and find myself repeating to my kids) is “measure twice, cut once.”  That is, make sure the part fits before you make it permanent.  The parents of the good people of Zimmer apparently never imparted such wisdom to their kids.

41Z6K8E2MNL._SX300_

Zimmer has now had to recall a part of its Persona artificial knee implant, specifically, the Persona porous coated, uncemented trabecular metal tibial plate.  Say that three times fast.  It seems that Zimmer began selling its knee implant without doing any clinical trials first.  This is the same problem Stryker had with its hip implants recently.

Zimmer Persona knee components can become loose, causing swelling and pain, and develop radiolucent lines – large gaps between the parts of the implant and the bones – which can damage both the bones (called osteolysis) and the device itself.

What does this mean to you:

A couple of rhetorical questions come to mind.  Shouldn’t companies that make products, especially ones that get implanted inside your body, have to test them first?  And how does one actually recall a device AFTER its been implanted?

In addition, Marlboro will sponsor the Komen 5k race

Mark Twain once said that golf is a good walk spoiled.  Truth be told, I  tend to agree with him.  But people nonetheless seem to enjoy the activity, whether they’re out strolling the fairway or going for the long ball.

hip

Hopefully, then, the irony was not lost this week when it was announced that the PGA Tour would be sponsored by – wait for it – Stryker Orthopedics.  Yes, that Stryker Orthopedics.  The one that made 20,000 defective ABG II and Rejuvenate metal hip implants.  The ones that would be bad for golfers (or anyone else who likes to, you know, move) to use.

What does this mean to you:

Remember that advertising and corporate sponsorship can be as much about framing and creating a positive public image as about selling products.

And now we wait

A jury in New Jersey has begun deliberating on one of the first trials involving surgical or transvaginal mesh.

waiting

The outcome of this early “bell weather” trial will impact how the mesh manufacturers approach the thousands of remaining cases where women suffered bleeding, infection, pain, and urinary problems from the mesh implants.

 

What does this mean to you:

Though it may seem distant and unrelated, early trials in cases like this can have massive legal ripple effects for the remaining individual claims.